# Resorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers

> **NCT03398538** · NA · COMPLETED · sponsor: **ETS Wound Care, LLC** · enrollment: 40 (actual)

## Conditions studied

- Diabetic Foot Ulcer
- Ulcer Foot
- Diabetic Foot

## Interventions

- **OTHER:** Offloading
- **OTHER:** Additional (outer) Dressing Application
- **OTHER:** Mirragen Wound Matrix Dressing
- **OTHER:** Fibracol Wound Dressing

## Key facts

- **NCT ID:** NCT03398538
- **Lead sponsor:** ETS Wound Care, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-26
- **Primary completion:** 2018-10-31
- **Final completion:** 2018-10-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03398538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03398538, "Resorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03398538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*